Resultados de la búsqueda 71-80 of 10776 for Monoclonal Antibodies

  1. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

  2. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving ...

  3. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

  4. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving ...

  5. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Tumors with high number of mutations may respond well to immunotherapy. Immunotherapy with monoclonal antibodies such as ipilimumab and nivolumab may help the ...

  6. Hematología - Ensayos clínicos

    Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

  7. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Tumors with high number of mutations may respond well to immunotherapy. Immunotherapy with monoclonal antibodies such as ipilimumab and nivolumab may help the ...

  8. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Monoclonal antibodies, such as obinutuzumab, may interfere with the ability of cancer cells to grow and spread. It is not yet known whether giving ...

  9. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Immunotherapy with monoclonal antibodies, such as pembrolizumab, may help the body's immune system attack the cancer, and may interfere with the ability of ...

  10. Oncología (médica) - Ensayos clínicos - Mayo Clinic

    Tumors with high number of mutations may respond well to immunotherapy. Immunotherapy with monoclonal antibodies such as ipilimumab and nivolumab may help the ...